Gland Pharma Limited

NSE:GLAND.NS

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

🌿 Fertilizers

💻 Telehealth

Location

India

Market Cap

USD 3.28 B

Share Price

USD 19.89

Avg Daily Volume

291,769

Change (1 day)

1.04%

Change (1 year)

-9.09%

Change (YTD)

-4.30%

Gland Pharma Limited Operating Income Margin for the year ending March 31, 2025: 30.86%

Gland Pharma Limited Operating Income Margin is 30.86% for the year ending March 31, 2025, a 5.82% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Gland Pharma Limited Operating Income Margin for the year ending March 31, 2024 was 29.16%, a 19.51% change year over year.
Gland Pharma Limited Operating Income Margin for the year ending March 31, 2024 was 29.16%, a 0.00% change year over year.
Gland Pharma Limited Operating Income Margin for the year ending March 31, 2023 was 24.40%, a -23.59% change year over year.
Gland Pharma Limited Operating Income Margin for the year ending March 31, 2022 was 31.93%, a -9.15% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

NSE: GLAND.NS

Gland Pharma Limited

CEO	Mr. Shyamakant Giri
IPO Date	Nov. 20, 2020
Location	India
Headquarters	Plot No. 11 & 84, TSIIC Phase: IV
Employees	4,217
Sector	🏥 Health Care
Industries Pharmaceuticals 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies 🌿 Fertilizers 💻 Telehealth

Description

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.